Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.63 |
| ▸ | MAPT | P10636 | 1/20 | 0.63 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.58 |
| ▸ | MKNK1 | Q9BUB5 | 1/20 | 0.58 |
| ▸ | MKNK2 | Q9HBH9 | 1/20 | 0.58 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.58 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.57 |
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.56 |
| ▸ | MEN1 | O00255 | 1/20 | 0.55 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.55 |
| ▸ | TSHR | P16473 | 1/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.55 |
| ▸ | TBXAS1 | P24557 | 2/20 | 0.54 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.50 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.50 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.50 |
| ▸ | BAZ2B | Q9UIF8 | 1/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.50 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.50 |
| ▸ | CYP51A1 | Q16850 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL27516102 | 0.98 | LMNA (0.61) | LMNAMAPTENPP2MKNK1MKNK2 | |
| SCHEMBL5801060 | 0.85 | LMNA (0.65) | LMNAMAPTENPP2MKNK1MKNK2 | |
| SCHEMBL21791731 | 0.84 | LMNA (0.62) | LMNAMAPTENPP2MKNK1MKNK2 | |
| SCHEMBL2532397 | 0.83 | LMNA (0.78) | LMNAMAPTENPP2MKNK1MKNK2 | |
| SCHEMBL15750592 | 0.82 | IDO1 (0.58) | LMNAMAPTCYP3A4LOXL2MEN1 | |
| Hydrochloric Acid SCHEMBL28701756 | 0.81 | LMNA (0.75) | LMNAMAPTENPP2MKNK1MKNK2 | |
| SCHEMBL255498 | 0.81 | MAOB (0.62) | LMNAMAPTENPP2MKNK1MKNK2 | |
| SCHEMBL857216 | 0.81 | ENPP2 (0.63) | LMNAMAPTENPP2MKNK1MKNK2 | |
| SCHEMBL22486535 | 0.81 | LMNA (0.58) | LMNAMAPTENPP2MKNK1MKNK2 | |
| SCHEMBL2460217 | 0.81 | NOTUM (0.63) | LMNAMAPTENPP2MKNK1MKNK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 117 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117025125-B | Flexible ultrathin conductive adhesive film and preparation method thereof | 江苏特丽亮新材料科技有限公司 | 2024-02-20 | — | — | CN | claimed |
| CN-117025125-A | Flexible ultrathin conductive adhesive film and preparation method thereof | 江苏特丽亮新材料科技有限公司 | 2023-11-10 | — | — | CN | claimed |
| CN-114174293-A | 4- (imidazo [1,2-a ] pyridin-3-yl) -pyrimidine derivatives | 默克专利股份公司 | 2022-03-11 | — | — | CN | claimed |
| CN-105189494-B | Imidazo[4,5-c]pyridine and pyrrolo[2,3-c]pyridine derivatives as SSAO inhibitors | 普罗克西梅根有限公司 | 2017-04-26 | — | — | CN | claimed |
| CN-102424671-B | Synthesis method of 4-chloro-2-cyano-1-dimethylamino-sulfonyl-5-(4-methylphenyl)imidazo | XIAN MODERN CHEMISTRY RES INST | 2014-05-14 | — | — | CN | claimed |
| CN-117025125-B | Flexible ultrathin conductive adhesive film and preparation method thereof | 江苏特丽亮新材料科技有限公司 | 2024-02-20 | — | — | CN | disclosed |
| CN-117025125-B | Flexible ultrathin conductive adhesive film and preparation method thereof | 江苏特丽亮新材料科技有限公司 | 2024-02-20 | — | — | CN | disclosed |
| CN-117025125-A | Flexible ultrathin conductive adhesive film and preparation method thereof | 江苏特丽亮新材料科技有限公司 | 2023-11-10 | — | — | CN | disclosed |
| CN-117025125-A | Flexible ultrathin conductive adhesive film and preparation method thereof | 江苏特丽亮新材料科技有限公司 | 2023-11-10 | — | — | CN | disclosed |
| US-20220267320-A1 | 4-(IMIDAZO[1,2-A]PYRIDIN-3-YL)-PYRIMIDINE DERIVATIVES | MERCK PATENT GMBH (DE) | 2022-08-25 | — | — | US | disclosed |
| CN-114174293-A | 4- (imidazo [1,2-a ] pyridin-3-yl) -pyrimidine derivatives | 默克专利股份公司 | 2022-03-11 | — | — | CN | disclosed |
| US-11186583-B2 | 5-alkylthio-7-[(4-arylbenzyl)amino]-1(2)H-pyrazolo[4,3-d]pyrimidines for treatment of lymphoma | UNIVERZITA PALACKEHO V OLOMOUCI (CZ) | 2021-11-30 | — | — | US | disclosed |
| US-20040209878-A1 | Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors | SCHERING CORPORATION AND PHARMACOPEIA, INC. | 2004-10-21 | — | — | US | disclosed |
| WO-2004022561-A1 | PYRAZOLOPYRIMIDINES AS CYCLIN-DEPENDENT KINASE INHIBITORS | SCHERING CORPORATION (US) | 2004-03-18 | — | — | WO | disclosed |
| EP-0358284-B1 | Derivatized alkanolamines as cardiovascular agents | SCHERING AG (DE) | 1997-08-20 | — | — | EP | disclosed |
| CN-1016309-B | BIOLOGICAL LETHAL AGENT COMPOSITION | ISHIHARA SANGYO KAISHA (JP) | 1992-04-22 | — | — | CN | disclosed |
| US-5051423-A | Derivatized alkanolamines as cardiovascular agents | SCHERING AG (DE) | 1991-09-24 | — | — | US | disclosed |
| EP-0358284-A2 | Derivatized alkanolamines as cardiovascular agents | SCHERING AKTIENGESELLSCHAFT (DE) | 1990-03-14 | — | — | EP | disclosed |
| WO-1990000548-A2 | DERIVATIZED ALKANOLAMINES AS CARDIOVASCULAR AGENTS | SCHERING AKTIENGESELLSCHAFT BERLIN AND BERGKAMEN (DE) | 1990-01-25 | — | — | WO | disclosed |
| CN-88101228-A | Imidazolium compounds and the biocides that contains this compound that is used for controlling harmful organism | — | 1988-12-07 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220267320-A1 | 4-(IMIDAZO[1,2-A]PYRIDIN-3-YL)-PYRIMIDINE DERIVATIVES | NCOA3, NCOR1, NCOA4 | LMNA 3635/4885MAPT 4822/4885ENPP2 2145/4885 |
| US-20040209878-A1 | Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors | CDK2, CDK1, CDK5 | LMNA 2221/4885MAPT 3483/4885ENPP2 2063/4885 |
| US-11186583-B2 | 5-alkylthio-7-[(4-arylbenzyl)amino]-1(2)H-pyrazolo[4,3-d]pyrimidines for treatment of lymphoma | TK1, DCK, CCNK | LMNA 2199/4885MAPT 4672/4885ENPP2 1793/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.